Dr. Ajay Gautam is Executive Director and Head of Collaborations for Asia Pacific & Emerging Markets for AstraZeneca’s IMED Biotech Unit based in Shanghai, China. In this role, he leads the development and implementation of AstraZeneca’s innovative medicines and early development strategy and collaborations in countries such as China, Australia, Korea, Israel, Singapore, Russia, Turkey and Brazil amongst others.